MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2026 International Congress

    RESET-DBS: An exploratory study on the safety and efficacy of personalized burst-patterned deep brain stimulation (DBS) in Parkinson’s Disease (PD)

    F. Lange, L. Juarez Paz, P. Köberle, B. Duarte, G. Adacay, T. Sil, M. Reich, A. Kühn, M. Muthuraman, H. Bokil, J. Volkmann (Würzburg, Germany)

    Objective: To assess the safety and efficacy of a personalized burst patterned STN-DBS (bDBS) vs. conventional high-frequency DBS (cDBS). Background: A physiological rationale suggests possible…
  • 2026 International Congress

    Investigation of the Mendelian contribution of parkinsonism associated genes to Parkinson’s disease

    G. Cogan, K. Rousvoal, C. Tesson, L. Arnaud, A. Méneret, G. Mangone, S. Sambin, G. Kodjovi, A. Lanore, E. Leguern, J. Corvol, S. Lesage, A. Brice (Paris, France)

    Objective: To explore the diagnostic yield and clinical relevance of Parkinsonism associated genes (PAGs) screening in Parkinson’s disease (PD). Background: The contribution of well-known PD…
  • 2026 International Congress

    Incidence and Outcomes of Hip Fractures in Parkinsonism vs Non-Parkinson Population: A Systematic Review of the Literature

    U. Saini (Chandigarh, India)

    Objective: To assess hip fractures incidence in Parkinsonism patients and assess their outcome. Background: Parkinson's disease is associated with gait disturbance, postural instability, and increased…
  • 2026 International Congress

    Multiple System Atrophy Without Dysautonomia

    I. Wilkens, V. Ruf, Y. Compta, C. Troakes, J. Cohen, E. Lee, C. Nilsson, E. Englund, J. Levin, A. Pantelyat, J. Seemiller, S. Berger, J. van Swieten, E. Dopper, A. Rozemuller, G. Kovacs, N. Bendahan, A. Lang, G. Höglinger, F. Hopfner (Munich, Germany)

    Objective: TTo investigate the frequency, clinical characteristics, and disease trajectory of patients with MSA presenting without dysautonomia and to compare their course with patients showing…
  • 2026 International Congress

    A Patient-Directed AI-Enabled Platform for Continuous Personalised Parkinson’s Management

    E. Meinert, J. Schivers, A. Ananthakrishnan, C. Carroll (Newcastle, United Kingdom)

    Objective: To describe the co-design and staged evaluation of a novel AI-enabled digital health platform for Parkinson’s where structured patient and clinician feedback informs iterative…
  • 2026 International Congress

    Heart Rate Variability in Early Parkinson’s Disease

    SJ. Chung, D. Kang, J. Lee, PH. Lee, YJ. Kim, YH. Sohn (Seoul, Republic of Korea)

    Objective: This study aimed to investigate the clinical relevance of heart rate variability (HRV), which may indicate underlying autonomic nervous system activity, in patients with…
  • 2026 International Congress

    The influence of Parkinson’s disease duration on perceived quality of inpatient care

    L. Eickholt, C. Kruse, W. Aamodt (Philadelphia, USA)

    Objective: There are currently no disease-modifying therapies for persons with Parkinson’s disease (PD), and progressive symptoms contribute to increased risk of hospitalization, particularly in the…
  • 2026 International Congress

    Association of Glymphatic Flow at Diffusion Tensor Image with Motor Symptoms and Striatal Dopamine Degeneration in Parkinson’s Disease

    SJ. Chung, CJ. Park, PH. Lee, YH. Sohn, YJ. Kim (Seoul, Republic of Korea)

    Objective: This study aimed to investigate the association between the diffusion tensor image (DTI) analysis along the perivascular space (ALPS) index, dopamine transporter (DAT) availability…
  • 2026 International Congress

    Delayed-Onset Rapidly Progressive Parkinsonism After BCMA×CD3 Bispecific Antibody Therapy: A Case Report

    IF. Yang, TY. Chung, YF. Sung (Taipei, Taiwan)

    Objective: To describe a delayed-onset rapidly progressive parkinsonian syndrome with encephalopathy following BCMA×CD3 bispecific antibody therapy. Background: B-cell maturation antigen (BCMA) × CD3 bispecific antibodies…
  • 2026 International Congress

    Development of a Nationwide Parkinson’s Disease Cohort in Korea: Toward an Ethnicity-Specific Precision Medicine Platform

    JS. Kim, DW. Ryu, Y. Oh, S. Ha, SJ. Kim, ES. Oh, YJ. Kim, PH. Lee, SJ. Chung, SB. Koh, DY. Kwon, JW. Cho, JS. Baik, HI. Ma, TB. Ahn, HW. Lee, JK. Park, M. Kwon, YH. Koh, SW. Yoo (Seoul, Republic of Korea)

    Objective: To establish and longitudinally expand a nationwide Parkinson’s disease (PD) cohort in Korea (K-PD cohort) and develop an ethnicity-specific precision medicine platform integrating clinical,…
  • « Previous Page
  • 1
  • …
  • 18
  • 19
  • 20
  • 21
  • 22
  • …
  • 425
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley